Antibody-Drug Conjugates Market Overview 2026: The Next Era of Oncology
The Antibody-Drug Conjugates market trends for 2026 reflect a transformative shift toward “biological missiles” that redefine cancer care. Antibody-drug conjugates (ADCs) are a rapidly evolving class of therapeutics designed to…